| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Other
|
Homo sapiens
|
TXT
|
Apr 10, 2024
|
||||
| GSE188530 |
Exome analyses for RNA and genome DNA of fibroblast single-cell clones
|
|
5 |
|
Makii Fukami | Apr 10, 2024 | ||
| GSE188531 |
Sex-biased and random monoallelic expression of SHOX: implications for sex difference in height
|
|
25 |
|
Makii Fukami | Apr 10, 2024 | ||
| GSE224204 |
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
|
|
117 |
|
Daniel Savic | Apr 10, 2024 | ||
| GSE225263 |
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment [MPRA]
|
|
|
64 |
|
Daniel Savic | Apr 10, 2024 | |
| GSE240582 |
Small-molecule Inhibition of METTL3 Suppresses Tumor Growth and Promotes Neuroblastoma Differentiation [meRIP-Seq]
|
|
|
44 |
|
Susan L Cohn | Apr 10, 2024 | |
| GSE240595 |
Small-molecule Inhibition of METTL3 Suppresses Tumor Growth and Promotes Neuroblastoma Differentiation
|
|
110 |
|
Susan L Cohn | Apr 10, 2024 | ||
| GSE245324 |
Dynamics and consequences of widespread transcript isoform changes during neuronal differentiation [ONT-Seq]
|
|
|
9 | Dr. Andreas Mayer | Apr 10, 2024 | ||
| GSE248774 |
Immune modulation with RANKL-blockade through denosumab treatment in cancer patients
|
|
|
69 |
|
Mark Bridge | Apr 10, 2024 | |
| GSE255375 |
Targeting lipid metabolism in pancreatic cancer [CRISPR]
|
|
|
3 |
|
Brian Magnuson | Apr 10, 2024 | |
| GSE255378 |
Targeting lipid metabolism in pancreatic cancer
|
|
9 |
|
Brian Magnuson | Apr 10, 2024 |
